Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever

Journal article

Background Drug-resistant enteric fever is increasingly common in the Indian subcontinent. Correctly determining azithromycin resistance matters where drug-resistant enteric fever is common and oral therapy necessary.
Case report In two patients returning from Pakistan to the UK with cephalosporin-resistant Salmonella enterica serovar Typhi, gradient strip testing erroneously indicated azithromycin resistance; the errors were detected by repeat testing and confirmed by whole genome sequencing.
Results Both patients were treated with meropenem and, when revised susceptibility results were known, with azithromycin, allowing a switch to oral therapy.
Conclusion As cephalosporin resistance becomes more common, azithromycin will be key for treating enteric fever and optimizing practice in susceptibility testing will be crucial. Practitioners should be aware of key steps to minimize error in azithromycin susceptibility testing, and should be alert for possible errors when reported azithromycin resistance is discordant with known prevalence of resistance.

Authors: Skittrall, JP; Levy, D; Obichukwu, C; Gentle, A; Chattaway, MA

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: British Infection Association
• Journal: Clinical Infection in Practice
• Volume: 10
• Article number: 100069
• Publication date: 2021-02-27
• Acceptance date: 2022-02-09
• DOI: 10.1016/j.clinpr.2021.100069
• EISSN: 2590-1702
• Language: English
• Keywords: typhoid fever; azithromycin; FFR; microbial drug resistance; microbial sensitivity tests; salmonella infections